Quick answer: Buyers value a supplement company on adjusted EBITDA, and on whether that profit would continue without heavy marketing. A brand is judged on repeat purchase, subscription share, the real cost of acquiring customers and dependence on one marketplace or ad platform. A contract manufacturer is judged on customer concentration, quality systems and capacity. Both are examined for regulatory compliance, claims, ingredient sourcing and product liability, which can produce price reductions or specific indemnities.
Key points
- The key question for a brand is how much profit remains if growth marketing stops. A buyer separates spending that maintains revenue from spending that buys new customers.
- Platform dependence is a concentration risk. A brand that sells mainly through one marketplace or advertising channel can be affected by a policy change it does not control.
- Compliance records are part of the price. Manufacturing practices, testing, labeling and claims substantiation are reviewed, and gaps lead to indemnities or reductions.
- Contract manufacturers and brands are valued differently. Manufacturers depend on customer relationships and quality systems, while brands depend on consumer loyalty and formulation ownership.
Two businesses with the same name
“Supplement company” covers two quite different models, and buyers take care to separate them. A brand owns the customer, the formula and the marketing, and often outsources production. A contract manufacturer produces for other brands and depends on its customers, its quality systems and its plant. Some companies are both. Each model has different risks, and a buyer builds its view of earnings and risk around the one it is buying.
Brands often grow quickly through online channels, where a good month can be bought with advertising. That is why buyers treat their profit with caution. Reported EBITDA tells them what the company earned. They want to know what it would earn at a steady level of spending.
Public-market reference data
There is no public industry group specific to dietary supplements. The January 2026 data for two nearby consumer-products groups gives some context: the household products group, with 110 US-listed firms, shows an enterprise value to EBITDA multiple of 13.2x, and the food processing group, with 78 firms, shows 10.0x.[1]
Public-company reference data, United States, as of January 2026[1][2]
| Damodaran industry group | US-listed firms | EV / EBITDA | EV / EBIT | EBITDA margin | Gross margin |
|---|---|---|---|---|---|
| Household Products | 110 | 13.2x | 16.2x | 22.3% | 51.0% |
| Food Processing | 78 | 10.0x | 13.6x | 15.2% | 23.2% |
The multiples cover companies in each group that have positive EBITDA; the margins come from the same author's separate margin dataset for the same industry groups. Most private companies are smaller, less liquid and less diversified than these public companies, so private-company transaction multiples differ, and often sit below them. No Damodaran group is specific to dietary supplements. These two are the nearest consumer-products groups, and neither describes a supplement company closely.
Neither group describes a supplement company closely, and both consist of larger firms with broad distribution. They show the general range at which the market values consumer-products earnings. A buyer will price a private supplement business on its own quality of earnings, growth and risks. The guide to valuation multiples explains how public data is adjusted.
What buyers examine in a supplement brand
Repeat revenue and cohorts. Buyers want customer cohorts by month of first purchase, showing how much of each cohort buys again and for how long. A business whose revenue comes mostly from existing customers has different economics from one that must replace its customers every year.
Marketing efficiency. The cost of acquiring a customer, compared with the profit that customer produces over time, is the central metric. Buyers also separate marketing that sustains existing revenue from marketing that buys growth, because the first is a cost of keeping the business and the second is discretionary.
Channel concentration. Sales through one marketplace, one social platform or one retailer expose the company to account restrictions, policy changes and algorithm shifts. The customer concentration guide applies by analogy.
Refunds, returns and chargebacks. Direct sellers face refund requests and payment disputes. Buyers test whether reserves are adequate and whether rates have been rising.
Sales tax and other compliance. Sellers who ship to customers in many states may have sales tax collection obligations that were not met. Buyers ask for the analysis and may treat historical exposure as a debt-like item.
Product mix. Dependence on one or two hero products raises the risk of a single event, such as a formulation problem or a new competitor, reducing results.
What buyers examine in a contract manufacturer
Customer concentration. A few brand customers may account for most output. Buyers ask for contract terms, volumes and the likelihood that customers move production in-house or to others.
Quality systems and capacity. Documented manufacturing practices, testing, supplier qualification and audit results are central. So are line utilization and the ability to take on volume.
Formulations and intellectual property. Who owns what, and whether the manufacturer has rights to formulas it developed for customers.
Raw material sourcing. Dependence on a few suppliers, long lead times and price volatility are examined.
Compliance, claims and liability
Supplements are regulated, and buyers will review compliance as part of diligence. Topics include manufacturing and testing practices, labeling and the substantiation behind claims, the handling of consumer complaints and reports of adverse events, and any correspondence with regulators. Insurance coverage and the history of product liability claims are also reviewed. This guide does not describe the legal requirements, which depend on the product and the jurisdiction, and a sale should involve counsel who works in the category. Strong, documented compliance supports price. Gaps lead to specific indemnities, escrows or price reductions.
Adjustments and the quality of earnings
The add-back guide covers common adjustments. In this category, growth marketing is the contested item. Owners often propose to add back part of advertising spend as discretionary. Buyers test whether revenue would fall if the spending did.
Illustrative example: Why a growth marketing add-back is rarely worth its face value
A direct-to-consumer brand reports revenue of $12,000,000 and EBITDA of $1,800,000. Marketing spend is $3,000,000, and the customers it acquired produced $4,000,000 of first-year revenue. The contribution margin before marketing is 55 percent. The owner proposes adding back $1,000,000 of marketing as growth spending. The buyer reasons that cutting $1,000,000 of marketing would reduce first-year revenue from new customers by about $1,333,333 and contribution by about $733,333. EBITDA would rise by only $266,667, and the loss of those customers would reduce repeat revenue in later years. The buyer accepts a small fraction of the add-back, or none. At an illustrative 6.0x, the difference between accepting all $1,000,000 and accepting $266,667 is about $4,400,000 of price. The figures are invented to show the reasoning and are not benchmarks.
Who buys supplement companies
Strategic buyers include larger nutrition and consumer health companies, retailers with private brands and other brand owners seeking categories or channels. Private equity firms and brand aggregators look for businesses with loyal customers and proven marketing. Contract manufacturers attract buyers that want capacity or capabilities, including other manufacturers and financial investors building platforms.
Structure reflects uncertainty about sustainability. Buyers often propose earnouts tied to revenue or gross profit, as the earnout guide explains, and they request specific indemnities for compliance issues.
Preparing for a sale
- Prepare cohort data by month of first purchase, with revenue, margin and retention.
- Reconcile marketing spend to new customer acquisition by channel.
- Summarize sales by marketplace and platform, with account status and any restrictions.
- Collect quality, testing and compliance documentation, and the agreements with manufacturers and suppliers.
- Confirm ownership of formulas, trademarks and domain names.
- Review sales tax collection and refund reserves.
See the consumer manufacturing series for related industries.
Frequently asked questions
Do buyers pay more for subscription revenue?
Usually, if the data supports it. Subscriptions provide visibility, but buyers test retention by cohort, the discounts used to win subscribers, cancellation behavior and the cost of reactivating lapsed customers. A large subscription base with high churn is less valuable than the headline suggests.
Who owns the formula, the brand or the manufacturer?
It should be spelled out in writing. When a brand uses a contract manufacturer, the agreements should state who owns the formulations, whether the manufacturer may sell similar products to others and what happens to the formula if the relationship ends. Ambiguity here is a diligence issue.
How do buyers view marketplace dependence?
As a concentration risk similar to relying on one large customer. They ask what share of revenue and profit comes through each marketplace or ad platform, how the account is managed and what happens if it is restricted. A diversified channel mix supports a higher price.
Is compliance a big part of diligence?
Yes. Buyers review manufacturing and testing records, supplier qualification, labeling, advertising claims and the handling of consumer complaints and adverse event reports. They also check insurance and any regulator correspondence. Counsel with experience in the category should be involved.
Need a valuation you can use in a sale or acquisition decision?
The Impetus Group prepares transactional valuations from the standpoint of strategic and financial buyers. A valuation is a standalone engagement with its own scope and fee, and it can be the first step before a sale or acquisition process.
Related guides
- EBITDA Add-Backs: What Buyers Accept and What They Reject: Learn which EBITDA add-backs buyers accept in a sale, which they reject, and how adjusted EBITDA changes enterprise value, with a worked illustration.
- Customer Concentration and Valuation: How Buyers Price the Risk: Why buyers pay less for businesses that depend on a few customers, how they measure concentration, and what owners can do to reduce the discount before a sale.
- Quality of Earnings Report: What It Is and What Buyers Test: A quality of earnings report tests whether a company’s reported profit is real and repeatable. See what buyers examine, how it affects price and how sellers prepare.
- What Drives the Value of a Business: The Factors Buyers Weigh: Buyers pay for future cash flow and discount it for risk. See the factors that raise or lower what a company is worth, from earnings quality to owner dependence.
More in consumer manufacturing
- Personal care and beauty product makers: How buyers value personal care and beauty product makers: brand momentum, retailer terms, returns, formulation ownership, hero products and public multiples.
- Pet food and pet product manufacturers: How buyers value pet food and pet product makers: consumable loyalty, recall sensitivity, channel mix, plant capacity, add-backs and public multiples.
Sources
- Enterprise Value Multiples by Sector (US), data as of January 2026. Aswath Damodaran, NYU Stern School of Business. Accessed October 8, 2026.
- Operating and Net Margins by Sector (US), data as of January 2026. Aswath Damodaran, NYU Stern School of Business. Accessed October 8, 2026.
This guide is general education. It is not a valuation opinion, appraisal, investment advice, or legal or tax advice. How these guides are made.